Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1966 1
1967 2
1969 1
1970 1
1972 2
1976 1
1977 1
1982 1
1983 1
1984 2
1985 2
1987 3
1988 3
1989 1
1990 2
1992 1
1993 2
1994 2
1995 3
1996 5
1997 3
1998 6
1999 4
2000 6
2001 8
2002 7
2003 8
2004 11
2005 5
2006 11
2007 4
2008 7
2009 3
2010 1
2011 3
2012 3
2015 3
2016 2
2017 5
2018 6
2019 5
2020 3
2021 9
2022 6
2023 5
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis.
Tanaka H, Tanzawa S, Misumi T, Makiguchi T, Inaba M, Honda T, Nakamura J, Inoue K, Kishikawa T, Nakashima M, Fujiwara K, Kohyama T, Ishida H, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Fujimoto N, Fukuda Y, Yasugi M, Tsuda T, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Shiraishi K, Matsutani N, Seki N. Tanaka H, et al. Among authors: ushijima s. Ther Adv Med Oncol. 2022 Dec 18;14:17588359221142786. doi: 10.1177/17588359221142786. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36570411 Free PMC article.
Postpsychotic collapse in schizophrenia.
Mino Y, Ushijima S. Mino Y, et al. Among authors: ushijima s. Acta Psychiatr Scand. 1989 Oct;80(4):368-74. doi: 10.1111/j.1600-0447.1989.tb02993.x. Acta Psychiatr Scand. 1989. PMID: 2573994
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study).
Tanzawa S, Makiguchi T, Tasaka S, Inaba M, Ochiai R, Nakamura J, Inoue K, Kishikawa T, Nakashima M, Fujiwara K, Kohyama T, Ishida H, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Miyamoto Y, Yokoyama T, Matsumoto C, Tsuda T, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Misumi T, Shiraishi K, Matsutani N, Seki N. Tanzawa S, et al. Among authors: ushijima s. Ther Adv Med Oncol. 2022 Jul 29;14:17588359221116603. doi: 10.1177/17588359221116603. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35923924 Free PMC article.
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study).
Tanzawa S, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Misumi T, Shiraishi K, Matsutani N, Tanaka H, Inaba M, Haruyama T, Nakamura J, Kishikawa T, Nakashima M, Iwasa K, Fujiwara K, Kohyama T, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Ishida H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Fujimoto N, Yokoyama T, Gemba K, Tsuda T, Nakagawa H, Ono H, Shimizu T, Nakamura M, Kusumoto S, Hayashi R, Shirasaki H, Ochi N, Aoe K, Kanaji N, Kashiwabara K, Inoue H, Seki N. Tanzawa S, et al. Among authors: ushijima s. Ther Adv Med Oncol. 2021 Feb 27;13:1758835921998588. doi: 10.1177/1758835921998588. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33717228 Free PMC article.
A global phylogenomic analysis of the shiitake genus Lentinula.
Sierra-Patev S, Min B, Naranjo-Ortiz M, Looney B, Konkel Z, Slot JC, Sakamoto Y, Steenwyk JL, Rokas A, Carro J, Camarero S, Ferreira P, Molpeceres G, Ruiz-Dueñas FJ, Serrano A, Henrissat B, Drula E, Hughes KW, Mata JL, Ishikawa NK, Vargas-Isla R, Ushijima S, Smith CA, Donoghue J, Ahrendt S, Andreopoulos W, He G, LaButti K, Lipzen A, Ng V, Riley R, Sandor L, Barry K, Martínez AT, Xiao Y, Gibbons JG, Terashima K, Grigoriev IV, Hibbett D. Sierra-Patev S, et al. Among authors: ushijima s. Proc Natl Acad Sci U S A. 2023 Mar 7;120(10):e2214076120. doi: 10.1073/pnas.2214076120. Epub 2023 Feb 27. Proc Natl Acad Sci U S A. 2023. PMID: 36848567 Free PMC article.
[Borderline personality disorder].
Ushijima S. Ushijima S. Ryoikibetsu Shokogun Shirizu. 2003;(39):351-3. Ryoikibetsu Shokogun Shirizu. 2003. PMID: 14503286 Review. Japanese. No abstract available.
168 results